{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T10:26:32Z","timestamp":1771669592978,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T00:00:00Z","timestamp":1629676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T00:00:00Z","timestamp":1629676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>This article is a case report of pseudoxanthoma elasticum (PXE) which was diagnosed based on significant angioid streaks (AS) with choroidal neovascularization (CNV) and regain normal visual function by intravitreal injection with Conbercept.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 51-year-old woman was referred to the Ophthalmology Department of Qingdao Municipal Hospital (Qingdao, China) on September 14, 2020 for metamorphopsia and loss of vision in the left eye in the preceding three days. Past history: high myopia for more than 30\u2009years, best corrected visual acuity (BCVA) of both eyes was 1.0 (5\u2009m Standard Logarithm Visual Acuity chart in decimal notations), hypertension for six years, and cerebral infarction two years ago, no history of ocular trauma or surgeries or similar patients in family was documented. We used methods for observation, including fundus examination, optical coherence tomography (OCT), fluorescein angiography combined with indocyanine green angiography (FFA\u2009+\u2009ICGA). Due to her symptoms and manifestations, along with the appearance of her neck skin, which resembled \u2018chicken skin\u2019, we speculated that she should be further examined at the Department of Dermatology by tissue paraffin section and molecular pathology analyses, and the diagnosis of PXE was then confirmed. After intravitreal injection with Conbercept (10\u2009mg\/ml, 0.2\u2009ml, Chengdu Kanghong Biotechnologies Co., Ltd.; Chengdu, Sichuan, China) she regained her BCVA.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This patient regained her best corrected visual acuity through intravitreal injection with Conbercept. To the best of our knowledge, no publications are available on cases in which a vision loss and the normal visual function can be reverted by intravitreal injection with Conbercept. Although PXE is a disease with low incidence and thus no effective cure established, targeted symptomatic treatment can effectively retard the disease progression and improve visual function, such as intravitreal injection with Conbercept.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12886-021-02069-0","type":"journal-article","created":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T09:21:55Z","timestamp":1629710515000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A case report: pseudoxanthoma elasticum diagnosed based on ocular angioid streaks and the curative effect of Conbercept treatment"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6343-9879","authenticated-orcid":false,"given":"Chaoxiong","family":"Cui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhanyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ding","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,8,23]]},"reference":[{"issue":"2","key":"2069_CR1","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1136\/jmg.11.2.152","volume":"11","author":"P FM.","year":"1974","unstructured":"FM. P. Autosomal dominant pseudoxanthoma elasticum. J Med Genet. 1974;11(2):152\u20137. https:\/\/doi.org\/10.1136\/jmg.11.2.152.","journal-title":"J Med Genet"},{"issue":"2","key":"2069_CR2","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.yexcr.2017.09.001","volume":"360","author":"I Faust","year":"2017","unstructured":"Faust I, Donhauser E, Fischer B, Ibold B, Kuhn J, Knabbe C, et al. Characterization of dermal myofibroblast differentiation in pseudoxanthoma elasticum. Exp Cell Res. 2017;360(2):153\u201362. https:\/\/doi.org\/10.1016\/j.yexcr.2017.09.001.","journal-title":"Exp Cell Res"},{"issue":"8","key":"2069_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0070544","volume":"8","author":"Q Wang","year":"2013","unstructured":"Wang Q, Li T, Wu Z, Wu Q, Ke X, Luo D, et al. Novel VEGF decoy receptor fusion protein conbercept targeting multiple VEGF isoforms provide remarkable anti-angiogenesis effect in vivo. PLoS One. 2013;8(8):e70544. https:\/\/doi.org\/10.1371\/journal.pone.0070544.","journal-title":"PLoS One"},{"issue":"3","key":"2069_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0057642","volume":"8","author":"Z Wu","year":"2013","unstructured":"Wu Z, Zhou P, Li X, Wang H, Luo D, Qiao H, et al. Structural characterization of a recombinant fusion protein by instrumental analysis and molecular modeling. PLoS One. 2013;8(3):e57642. https:\/\/doi.org\/10.1371\/journal.pone.0057642.","journal-title":"PLoS One"},{"issue":"6","key":"2069_CR5","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/nm0603-669","volume":"9","author":"NGH Ferrara","year":"2003","unstructured":"Ferrara NGH, LeCouter J. The biology of VEGF and its receptors. Nat Med. 2003;9(6):669\u201376. https:\/\/doi.org\/10.1038\/nm0603-669.","journal-title":"Nat Med"},{"issue":"12","key":"2069_CR6","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.2174\/1389450121666200428101738","volume":"21","author":"C Campa","year":"2020","unstructured":"Campa C. New anti-VEGF drugs in ophthalmology. Curr Drug Targets. 2020;21(12):1194\u2013200. https:\/\/doi.org\/10.2174\/1389450121666200428101738.","journal-title":"Curr Drug Targets"},{"issue":"1","key":"2069_CR7","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12886-018-0807-1","volume":"18","author":"J Zhang","year":"2018","unstructured":"Zhang J, Liang Y, Xie J, Li D, Hu Q, Li X, et al. Conbercept for patients with age-related macular degeneration: a systematic review. BMC Ophthalmol. 2018;18(1):142. https:\/\/doi.org\/10.1186\/s12886-018-0807-1.","journal-title":"BMC Ophthalmol"},{"issue":"7","key":"2069_CR8","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1097\/IAE.0b013e3182914d2b","volume":"33","author":"MFR Gliem","year":"2013","unstructured":"Gliem MFR, Fimmers R, Brinkmann CK, Holz FG, Charbel IP. Treatment of choroidal neovascularization due to angioid streaks: a comprehensive review. Retina. 2013;33(7):1300\u201314. https:\/\/doi.org\/10.1097\/IAE.0b013e3182914d2b.","journal-title":"Retina"},{"issue":"8","key":"2069_CR9","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1186\/1752-1947-8-458","volume":"22","author":"MCMA Savastano","year":"2014","unstructured":"Savastano MCMA, Zinzanella G, Falsini B, Caporossi A. Successful long-term management of choroidal neovascularization secondary to angioid streaks in a patient with pseudoxanthoma elasticum: a case report. J Med Case Rep. 2014;22(8):458.","journal-title":"J Med Case Rep"},{"issue":"8","key":"2069_CR10","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1007\/s00417-017-3685-y","volume":"255","author":"G Mimoun","year":"2017","unstructured":"Mimoun G, Ebran JM, Grenet T, Donati A, Cohen SY, Ponthieux A. Ranibizumab for choroidal neovascularization secondary to pseudoxanthoma elasticum: 4-year results from the PIXEL study in France. Graefes Arch Clin Exp Ophthalmol. 2017;255(8):1651\u201360. https:\/\/doi.org\/10.1007\/s00417-017-3685-y.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"2","key":"2069_CR11","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1444-0938.2010.00559.x","volume":"94","author":"I Georgalas","year":"2011","unstructured":"Georgalas I, Tservakis I, Papaconstaninou D, Kardara M, Koutsandrea C, Ladas I. Pseudoxanthoma elasticum, ocular manifestations, complications and treatment. Clin Exp Optom. 2011;94(2):169\u201380. https:\/\/doi.org\/10.1111\/j.1444-0938.2010.00559.x.","journal-title":"Clin Exp Optom"},{"issue":"7","key":"2069_CR12","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1097\/IAE.0b013e318207d1dc","volume":"31","author":"RPCIP Finger","year":"2011","unstructured":"Finger RPCIP, Schmitz-Valckenberg S, Holz FG, Scholl HN. Long-term effectiveness of intravitreal bevacizumab for choroidal neovascularization secondary to angioid streaks in pseudoxanthoma elasticum. Retina. 2011;31(7):1268\u201378. https:\/\/doi.org\/10.1097\/IAE.0b013e318207d1dc.","journal-title":"Retina"},{"issue":"2","key":"2069_CR13","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s00417-019-04551-4","volume":"258","author":"M Gliem","year":"2020","unstructured":"Gliem M, Birtel J, Herrmann P, Fimmers R, Berger M, Coch C, et al. Aflibercept for choroidal neovascularizations secondary to pseudoxanthoma elasticum: a prospective study. Graefes Arch Clin Exp Ophthalmol. 2020;258(2):311\u20138. https:\/\/doi.org\/10.1007\/s00417-019-04551-4.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"5","key":"2069_CR14","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1358\/dot.2020.56.5.3137164","volume":"56","author":"LTC Ferro Desideri","year":"2020","unstructured":"Ferro Desideri LTC, Nicol\u00f2 M. An update on conbercept to treat wet age-related macular degeneration. Drugs Today (Barc). 2020;56(5):311\u201320. https:\/\/doi.org\/10.1358\/dot.2020.56.5.3137164.","journal-title":"Drugs Today (Barc)"},{"issue":"5","key":"2069_CR15","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.jid.2016.11.042","volume":"137","author":"Q Li","year":"2017","unstructured":"Li Q, Kingman J, van de Wetering K, Tannouri S, Sundberg JP, Uitto J. Abcc6 knockout rat model highlights the role of liver in PPi homeostasis in pseudoxanthoma Elasticum. J Invest Dermatol. 2017;137(5):1025\u201332. https:\/\/doi.org\/10.1016\/j.jid.2016.11.042.","journal-title":"J Invest Dermatol"},{"issue":"2","key":"2069_CR16","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/ced.13308","volume":"43","author":"S Kawashima","year":"2018","unstructured":"Kawashima S, Togawa Y, Miyachi H, Matsue H. Dermoscopic features of pseudoxanthoma elasticum. Clin Exp Dermatol. 2018;43(2):175\u20139. https:\/\/doi.org\/10.1111\/ced.13308.","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"2069_CR17","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13023-017-0639-8","volume":"12","author":"DP Germain","year":"2017","unstructured":"Germain DP. Pseudoxanthoma elasticum. Orphanet J Rare Dis. 2017;12(1):85. https:\/\/doi.org\/10.1186\/s13023-017-0639-8.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"2069_CR18","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s12886-017-0569-1","volume":"17","author":"K Kakurai","year":"2017","unstructured":"Kakurai K, Hayashi M, Yamada K, Ishizaki N, Yonemoto Y, Morishita S, et al. A case of pseudoxanthoma elasticum with proliferative diabetic retinopathy. BMC Ophthalmol. 2017;17(1):184. https:\/\/doi.org\/10.1186\/s12886-017-0569-1.","journal-title":"BMC Ophthalmol"},{"key":"2069_CR19","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/fgene.2013.00014","volume":"4","author":"M Gliem","year":"2013","unstructured":"Gliem M, Zaeytijd JD, Finger RP, Holz FG, Leroy BP, Charbel Issa P. An update on the ocular phenotype in patients with pseudoxanthoma elasticum. Front Genet. 2013;4:14.","journal-title":"Front Genet"},{"key":"2069_CR20","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ajo.2020.07.022","volume":"220","author":"S Risseeuw","year":"2020","unstructured":"Risseeuw S, Ossewaarde-van Norel J, van Buchem C, Spiering W, Imhof SM, van Leeuwen R. The extent of Angioid streaks correlates with macular degeneration in pseudoxanthoma Elasticum. Am J Ophthalmol. 2020;220:82\u201390. https:\/\/doi.org\/10.1016\/j.ajo.2020.07.022.","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"2069_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2009.08.003","volume":"29","author":"JC Booij","year":"2010","unstructured":"Booij JC, Baas DC, Beisekeeva J, Gorgels TG, Bergen AA. The dynamic nature of Bruch's membrane. Prog Retin Eye Res. 2010;29(1):1\u201318. https:\/\/doi.org\/10.1016\/j.preteyeres.2009.08.003.","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"2069_CR22","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ajo.2014.04.005","volume":"158","author":"M Gliem","year":"2014","unstructured":"Gliem M, Fimmers R, Muller PL, Brinkmann CK, Finger RP, Hendig D, et al. Choroidal changes associated with Bruch membrane pathology in pseudoxanthoma elasticum. Am J Ophthalmol. 2014;158(1):198\u2013207 e193. https:\/\/doi.org\/10.1016\/j.ajo.2014.04.005.","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"2069_CR23","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/s12185-019-02806-8","volume":"111","author":"NS Che Yaacob","year":"2020","unstructured":"Che Yaacob NS, Islam MA, Alsaleh H, Ibrahim IK, Hassan R. Alpha-hemoglobin-stabilizing protein (AHSP): a modulatory factor in beta-thalassemia. Int J Hematol. 2020;111(3):352\u20139. https:\/\/doi.org\/10.1007\/s12185-019-02806-8.","journal-title":"Int J Hematol"},{"issue":"12","key":"2069_CR24","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1136\/jmg.2004.030171","volume":"42","author":"N Chassaing","year":"2005","unstructured":"Chassaing N, Martin L, Calvas P, Le Bert M, Hovnanian A. Pseudoxanthoma elasticum: a clinical, pathophysiological and genetic update including 11 novel ABCC6 mutations. J Med Genet. 2005;42(12):881\u201392. https:\/\/doi.org\/10.1136\/jmg.2004.030171.","journal-title":"J Med Genet"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-021-02069-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-021-02069-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-021-02069-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T09:36:19Z","timestamp":1629711379000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-021-02069-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,23]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2069"],"URL":"https:\/\/doi.org\/10.1186\/s12886-021-02069-0","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,23]]},"assertion":[{"value":"20 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Qingdao Municipal Hospital Medical Ethics Committee reviewed the study and informed consent and agreed that the study is in accordance with the Helsinki Declaration principles, and fully respect the patient\u2019s informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"307"}}